12
Participants
Start Date
August 31, 2021
Primary Completion Date
July 24, 2022
Study Completion Date
July 24, 2022
Meropenem 1000 mg
Administration of meropenem after intraperitoneal administration via cycler-therapy in APD patients without peritonitis
Aztreonam 2000 mg
Administration of aztreonam after intraperitoneal administration via cycler-therapy in APD patients without peritonitis
automated peritoneal dialysis with following long time dwell
The cycler therapy, followed by a prolonged dwell, will be performed as outlined in the study protocol.
Sampling
The sampling of blood, dialysate, and urine will be performed as outlined in the study protocol.
UK St. Pölten, Sankt Pölten
Karl Landsteiner University of Health Sciences
OTHER
Medical University of Cologne
OTHER
University Hospital St. Polten
OTHER
University of Vienna
OTHER
Karl Landsteiner Insitute for Nephrology and Haemato-Oncology
NETWORK